SCHEDULE 13G
Statement of Beneficial Ownership
ALNYLAM PHARMACEUTICALS, INC. Filed Acc 0002100121-26-001039
Stakes reported in this filing
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X02/primary_doc.xml…